Hack The Box
The innovative Cyber Performance Center approach helps businesses present a united front against cybercrime by aligning cybersecurity and corporate goals.
NEW YORK, NY, LONDON, UK and SYDNEY, AUSTRALIA / ACCESSWIRE / April 10, 2024 / Companies can level up their cybersecurity defenses - eliminating the skills and knowledge gaps that criminals regularly exploit thanks to Hack The Box's Cyber Performance Center.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Hack The Box's Cyber Performance Center unites individual ability, business management practices, and the human factor in the cybersecurity industry and it is designed to help organizations take a coordinated approach to their cyber readiness, reducing the vulnerabilities created when cybersecurity is siloed or treated as a tick-box requirement.
Its innovative model transcends the limits of traditional cyber training, taking a 360º overview that considers a business's processes and technology investments along with the requirements of its cybersecurity teams. By matching processes and exercises to organizational outcomes it helps to align cybersecurity and business objectives.
Hack The Box's disruptive approach also directly addresses the key human element within corporate cybersecurity, focusing on the upskilling and development cyber professionals need to perform to their best while providing clear career paths to encourage retention and combat the increased burnout and fatigue within the sector. This is critical as the global cybersecurity industry currently faces a skills shortage of four million people.
It is estimated that, by next year over half of significant cyber incidents will be caused by human error or skill shortages1. The Cyber Performance Center approach helps organizations tackle their security as a company-wide goal, considering the needs of its cybersecurity team, business processes, and respective technology investments to promote a healthy security culture.
Hack The Box combines these three organizational pillars with a continuous learning journey based on the latest technologies, vulnerabilities, and solutions for all cybersecurity domains. The approach enables customers to create and maintain a robust cyber strategy, unlocking the skills of each member of their security teams, matching processes and exercises to organizational outcomes, and bridging the gap between cybersecurity and business objectives.
"At Hack The Box, we believe cybersecurity readiness is not just a technical requirement but a company-wide imperative, involving people, technology, and processes", highlights Haris Pylarinos, Founder and CEO at Hack The Box. "Only by taking into account the needs of an organization's cybersecurity team, its business processes, and respective technology investments, can a healthy security culture thrive. That's why we've developed the Cyber Performance Center approach, where our focus is on empowering cyber individuals and organizations to bring out the best version of themselves, day in and day out."
Hack The Box is the only Cyber Performance Center that builds on three critical pillars:
Continuous, gamified, hands-on upskilling from cybersecurity fundamentals to advanced scenarios.
Cybersecurity workforce development plans, baked into the fabric and objectives of organizations.
Career path programs and retention strategies to fight burnout, fatigue, and skill gaps.
Haris Pylarinos continues: "What makes Hack The Box different is that, unlike traditional training methods, we provide an all-in-one platform that serves as a single pane of glass for organizations and cybersecurity leaders to recruit, upskill, retain, and track their team's success. Cyber Performance Center marks the next stage of Hack The Box's evolution. We will continue to support the industry by acting as a vital ally in crafting high-performing security teams and organizations that put the human factor in the forefront."
ENDS
Notes to editors:
1 Predicts 2023: Cybersecurity Industry Focuses on the Human Deal, Gartner
Additional graphics available upon request.
About Hack The Box:
Hack The Box is the Cyber Performance Center with the mission to provide a human-first platform to create and maintain high-performing cybersecurity individuals and organizations. Hack The Box is the only platform that unites upskilling, workforce development, and the human focus in the cybersecurity industry, and it's trusted by organizations worldwide for driving their teams to peak performance. Offering an all-in-one environment for continuous growth, assessment, and recruitment, Hack The Box provides solutions for all cybersecurity domains. Launched in 2017, Hack The Box brings together the largest global cybersecurity community of more than 2.6 million platform members. Rapidly growing its international footprint and reach, Hack The Box is headquartered in the UK, with additional offices in the US, Australia, and Greece.
For more information, please visit hackthebox.com
Find us on:
LinkedIn - Facebook - Instagram - Twitter - Discord - YouTube
For press inquiries, please contact: pr@hackthebox.com
SOURCE: Hack The Box
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
PHYLA Announces a Series of International Collaborations With the University of Bradford and UPM and a Significant Government-Supported Land Regeneration Project in the Gambia10.12.2024 14:00:00 CET | Press release
LONDON, UK PHYLA and the University of Bradford join forces to develop marketable compounds, cosmetics and superfood products from the pongamia plant PHYLA has entered into a commercial agreement with the University of Bradford to develop marketable bio-compounds for cosmetics and superfood products derived from the pongamia (oil tree) plant which are cultivated in PHYLA's land regeneration projects. The partnership aims to leverage PHYLA's existing IP by applying specific extraction technologies which maximise the yield and value of bio-compounds and other plant-based products. Phyla's Pongamia Pods Phyla's high-density pongamia pod cluster Professor Anant Paradkar, Director of The Centre for Pharmaceutical Engineering Science (CPES) at the University of Bradford, commented: "We are thrilled to collaborate with PHYLA to advance the development of plant-based products. Our Centre has a long-standing commitment to green and sustainable extraction technologies, and this partnership align
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections10.12.2024 07:30:00 CET | Press release
Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals KNOXVILLE, TN / ACCESSWIRE / December 10, 2024 / VisiRose, a clinical-stage biotechnology company, is introducing Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT), a groundbreaking, non-invasive investigational treatment for infectious keratitis and other serious eye infections developed by the University of Miami Miller School of Medicine's Bascom Palmer Eye Institute (BPEI). VisiRose, a newly launched company of Provectus Biopharmaceuticals (OTCQB:PVCT) and the University, is focused on commercializing this innovative ocular research by combining a formulation of Provectus's pharmaceutical-grade bioactive synthetic small molecule Rose Bengal Sodium (RBS) and BPEI's light-based medical device to treat eye infections caused by bacteria, fungi, and parasites. RB PDAT offers a potential solution to the growing global problem of antimicrobial resistance (AMR), providing a broad-spectrum ocular thera
Young Girl Discovers a 3,500-year-old Egyptian Amulet9.12.2024 07:40:00 CET | Press release
During a family trip near an archaeological site in Hod Hasharon, 12-year-old Dafna Filshteiner found an ancient scarab. LONDON, UK / ACCESSWIRE / December 9, 2024 / Dafna Filshteiner, age 12, was recently hiking below the ancient site of Tel Qana in Hod Hasharon, when suddenly, to her surprise, she discovered an unusual find a beetle-like stone used as an Egyptian amulet about 3,500 years ago. "I was looking down at the ground to find porcupine needles and smooth pebbles," she says. "And suddenly I picked up an interesting stone. I showed it to my mother, and she said it was just an ordinary stone or a bead. But then I saw a decoration and stubbornly insisted it was more than that, so we searched on the Internet. There, we identified more photos of stones similar to what we had found. We realized that it was something special and immediately called the Antiquities Authority." The family turned to Mor Wiesel, an archaeologist at the Israel Antiquities Authority, who thanked Dafna and h
Loar Announces Launch of Public Offering9.12.2024 06:30:00 CET | Press release
WHITE PLAINS, NY / ACCESSWIRE / December 9, 2024 / Loar Holdings Inc. (NYSE:LOAR) ("Loar") announced today that it has launched the roadshow for the public offering of 4,750,000 shares of its common stock, including 1,583,333 shares offered by certain stockholders and 3,166,667 shares offered by Loar. In addition, such selling stockholders expect to grant the underwriters a 30-day option to purchase up to 712,500 additional shares of common stock at the public offering price, less underwriting discounts and commissions. Loar intends to use the net proceeds from this offering for repayment of borrowings outstanding under its credit agreement and, to the extent of any remaining proceeds, for general corporate purposes, including working capital. Loar will not receive any of the proceeds from the sale of common stock offered by the selling stockholders, including any common stock sold pursuant to any exercise by the underwriters of their option to purchase additional shares. Jefferies and
BioNxt Solutions Reports Progress on BNT23001 Development for Multiple Sclerosis Treatment9.12.2024 03:05:00 CET | Press release
VANCOUVER, BC / ACCESSWIRE / December 9, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, has achieved key milestones in the development of BNT23001, its proprietary sublingual thin-film (OFD) formulation of Cladribine for the treatment of Multiple Sclerosis (MS). These achievements in 2024 lay the groundwork for clinical trials and regulatory submissions in 2025, reinforcing BioNxt's commitment to advancing patient-centric therapeutic solutions. 2024 Milestones: Establishing a Strong Foundation for Cladribine Thin-Film Development Preclinical Success: BNT23001 demonstrated high absorption rates of Cladribine through sublingual delivery in pharmacokinetic (PK) studies conducted in animal models. These studies confirmed the product's bioequivalence to the originator therapy, Mavenclad®, and validated the thin-film's rapid absorption and safety profile. Toxicity studies furth
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom